CDH1 methylation in peritoneal washes as a prognostic factor for gastric cancer

Authors

DOI:

https://doi.org/10.33448/rsd-v11i2.25758

Keywords:

Gastric cancer; Peritoneal metastasis; Methylation; CDH1; Progressão tumoral.

Abstract

Gastric cancer is a major public health problem, considered the fifth most frequently diagnosed cancer worldwide. Peritoneal metastasis is the main causes of mortality related to gastric cancer. The hypermethylation of tumor suppressors genes is a promising factor for the development of predictive biomarkers. In gastric tumors, reduced expression of CDH1 suppressor gene contributes to tumor invasion and triggering metastasis. We aim to evaluate the promoter region methylation profile of the CDH1 gene as a peritoneal metastasis indicator in patients with gastric cancer. CDH1 methylation profile were evaluate in 47 samples of peritoneal washes from patients with gastric cancer by bisulfite sequencing PCR (BSP). Thirty-three CpGs sites in the CDH1 promoter region were individually evaluated. Samples with ≥ 10% of methylated CpGs sites were considered hypermethylated. Statistical analysis was performed by Fisher's Exact test using R-Studio program (p≤0.05). Twenty-nine (62%) samples showed hypermethylation in the promoter region of CDH1, with preferential methylation at the CpGs sites located in the region 5' upstream from gene. Statistical analysis showed that CDH1 hypermethylation was significantly different in patients with advanced stages of tumor depth of invasion (p=0.03). Our results suggest that CDH1 gene methylation analysis is a useful tool in predicting tumor progression and invasiveness in gastric cancer patients and could have a major impact for the field of precision cancer medicine.

References

Bentrem, D., Wilton, A., Mazumdar, M., Brennan, M., & Coit, D. (2005). The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Annals of Surgical Oncology, 12(5), 347–353. https://doi.org/10.1245/aso.2005.03.065

Bergman, Y., & Cedar, H. (2013). DNA methylation dynamics in health and disease. Nature Structural & Molecular Biology, 20(3), 274–281. https://doi.org/10.1038/nsmb.2518

Borges, B. do N., Santos, E. da S., Bastos, C. E. M. C., Pinto, L. C., Anselmo, N. P., Quaresma, J. A. S., Calcagno, D. Q., Burbano, R. M. R., & Harada, M. L. (2010). Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. Anticancer Research, 30(6), 2225–2233.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

Bruner, H. C., & Derksen, P. W. B. (2018). Loss of E-cadherin-dependent cell–cell adhesion and the development and progression of cancer. Cold Spring Harbor Perspectives in Biology, 10(3), a029330. https://doi.org/10.1101/cshperspect.a029330

Caldeira, J. R. F., Prando, E. C., Quevedo, F. C., Neto, F. A. M., Rainho, C. A., & Rogatto, S. R. (2006). CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer, 6(1), 48. https://doi.org/10.1186/1471-2407-6-48

Corn, P. G., Heath, E. I., Heitmiller, R., Fogt, F., Forastiere, A. A., Herman, J. G., & Wu, T. T. (2001). Frequent hypermethylation of the 5’ CpG island of E-cadherin in esophageal adenocarcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 7(9), 2765–2769.

Corn, P. G., Smith, B. D., Ruckdeschel, E. S., Douglas, D., Baylin, S. B., & Herman, J. G. (2000). E-cadherin expression is silenced by 5’ CpG island methylation in acute leukemia. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 6(11), 4243–4248.

Dumitrescu, R. G. (2018). Early epigenetic markers for precision medicine. Methods in Molecular Biology (Clifton, N.J.), 1856, 3–17. https://doi.org/10.1007/978-1-4939-8751-1_1

Fu, D.-G. (2015). Epigenetic alterations in gastric cancer (Review). Molecular Medicine Reports, 12(3), 3223–3230. https://doi.org/10.3892/mmr.2015.3816

Fujiwara, Y., Doki, Y., Taniguchi, H., Sohma, I., Takiguchi, S., Miyata, H., Yamasaki, M., & Monden, M. (2007). Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 10(4), 197–204. https://doi.org/10.1007/s10120-007-0436-5

Gao, P., Wang, S., Jing, F., Zhan, J., & Wang, Y. (2017). microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling. Cancer Biomarkers: Section A of Disease Markers, 19(1), 11–20. https://doi.org/10.3233/CBM-160167

Hiraki, M., Kitajima, Y., Koga, Y., Tanaka, T., Nakamura, J., Hashiguchi, K., Noshiro, H., & Miyazaki, K. (2011). Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients. Annals of Surgical Oncology, 18(10), 3013–3019. https://doi.org/10.1245/s10434-011-1636-0

Hiraki, M., Kitajima, Y., Sato, S., Nakamura, J., Hashiguchi, K., Noshiro, H., & Miyazaki, K. (2010). Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer. World Journal of Gastroenterology: WJG, 16(3), 330–338. https://doi.org/10.3748/wjg.v16.i3.330

Holubeková, V., Mendelová, A., Grendár, M., Meršaková, S., Kapustová, I., Jašek, K., Vaňochová, A., Danko, J., & Lasabová, Z. (2016). Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. Oncology Letters, 12(4), 2613–2621. https://doi.org/10.3892/ol.2016.5004

Hoskovec, D., Varga, J., Dytrych, P., Konecna, E., & Matek, J. (2017). Peritoneal lavage examination as a prognostic tool in cases of gastric cancer. Archives of Medical Science: AMS, 13(3), 612–616. https://doi.org/10.5114/aoms.2016.64044

Japanese Gastric Cancer Association. (2017). Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 20(1), 1–19. https://doi.org/10.1007/s10120-016-0622-4

Jones, P. A. (2012). Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature Reviews. Genetics, 13(7), 484–492. https://doi.org/10.1038/nrg3230

Katoh, M. (2005). Epithelial-mesenchymal transition in gastric cancer (Review). International Journal of Oncology, 27(6), 1677–1683.

Koch, A., Joosten, S. C., Feng, Z., de Ruijter, T. C., Draht, M. X., Melotte, V., Smits, K. M., Veeck, J., Herman, J. G., Van Neste, L., Van Criekinge, W., de Meyer, T., & van Engeland, M. (2018). Author Correction: Analysis of DNA methylation in cancer: location revisited. Nature Reviews. Clinical Oncology, 15(7), 467–467. https://doi.org/10.1038/s41571-018-0028-9

Kodera, Y., Nakanishi, H., Ito, S., Yamamura, Y., Kanemitsu, Y., Shimizu, Y., Hirai, T., Yasui, K., Kato, T., & Tatematsu, M. (2002). Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Annals of Surgery, 235(4), 499–506. https://doi.org/10.1097/00000658-200204000-00007

Li, Z., & Guo, Z. (2020). Comparison of CDH1 gene hypermethylation status in blood and serum among gastric cancer patients. Pathology Oncology Research: POR, 26(2), 1057–1062. https://doi.org/10.1007/s12253-019-00658-5

Ling, Z.-Q., Li, P., Ge, M.-H., Zhao, X., Hu, F.-J., Fang, X.-H., Dong, Z.-M., & Mao, W.-M. (2011). Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. International Journal of Molecular Medicine, 27(5), 625–635. https://doi.org/10.3892/ijmm.2011.640

Lisiecki, R., Kruszwicka, M., Spychała, A., & Murawa, D. (2017). Prognostic significance, diagnosis and treatment in patients with gastric cancer and positive peritoneal washings. A review of the literature. Reports of Practical Oncology and Radiotherapy: Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 22(6), 434–440. https://doi.org/10.1016/j.rpor.2017.08.004

Liu, D., Lu, M., Li, J., Yang, Z., Feng, Q., Zhou, M., Zhang, Z., & Shen, L. (2016). The patterns and timing of recurrence after curative resection for gastric cancer in China. World Journal of Surgical Oncology, 14(1), 305. https://doi.org/10.1186/s12957-016-1042-y

Lu F., Du G., Zheng S., Peng L., & Chen J. (2014). Detection of CDH1 gene methylation of suspension cells in abdominal lavage fluid from colorectal cancer patients and its clinical significance. Zhonghua wei chang wai ke za zhi [Chinese journal of gastrointestinal surgery], 17(11), 1133–1136.

Ma, Y. R., Siegal, G. P., & Wei, S. (2017). Reacquisition of E-cadherin expression in metastatic deposits of signet-ring cell carcinoma of the upper gastrointestinal system: a potential anchor for metastatic deposition. Journal of Clinical Pathology, 70(6), 528–532. https://doi.org/10.1136/jclinpath-2016-203959

Nojima, D., Nakajima, K., Li, L. C., Franks, J., Ribeiro-Filho, L., Ishii, N., & Dahiya, R. (2001). CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma. Molecular Carcinogenesis, 32(1), 19–27. https://doi.org/10.1002/mc.1060

Paget, S. (1989). The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Reviews, 8(2), 98–101.

Paolillo, M., & Schinelli, S. (2019). Extracellular matrix alterations in metastatic processes. International Journal of Molecular Sciences, 20(19), 4947. https://doi.org/10.3390/ijms20194947

Pathogenesis and treatment of Gastric Carcinoma: “An up-date with brief review”. (2007). The Internet journal of oncology, 4(1). https://doi.org/10.5580/490

Peixoto, P., Etcheverry, A., Aubry, M., Missey, A., Lachat, C., Perrard, J., Hendrick, E., Delage-Mourroux, R., Mosser, J., Borg, C., Feugeas, J.-P., Herfs, M., Boyer-Guittaut, M., & Hervouet, E. (2019). EMT is associated with an epigenetic signature of ECM remodeling genes. Cell Death & Disease, 10(3), 205. https://doi.org/10.1038/s41419-019-1397-4

Prieto-García, E., Díaz-García, C. V., García-Ruiz, I., & Agulló-Ortuño, M. T. (2017). Epithelial-to-mesenchymal transition in tumor progression. Medical Oncology (Northwood, London, England), 34(7), 122. https://doi.org/10.1007/s12032-017-0980-8

Prudkin, L., Liu, D. D., Ozburn, N. C., Sun, M., Behrens, C., Tang, X., Brown, K. C., Bekele, B. N., Moran, C., & Wistuba, I. I. (2009). Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, 22(5), 668–678. https://doi.org/10.1038/modpathol.2009.19

Rohde, C., Zhang, Y., Jurkowski, T. P., Stamerjohanns, H., Reinhardt*, R., & Jeltsch, A. (2008). Bisulfite sequencing Data Presentation and Compilation (BDPC) web server a useful tool for DNA methylation analysis. GBM Annual Spring meeting Mosbach 2008, 2008(Spring). https://doi.org/10.1240/sav_gbm_2008_m_002251

Sawada, T., Yashiro, M., Sentani, K., Oue, N., Yasui, W., Miyazaki, K., Kai, K., Fushida, S., Fujimura, T., Ohira, M., Kakeji, Y., Natsugoe, S., Shirabe, K., Nomura, S., Shimada, Y., Tomita, N., Hirakawa, K., & Maehara, Y. (2015). New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 18(1), 119–128. https://doi.org/10.1007/s10120-014-0338-2

Shenoy, S. (2019). CDH1 (E-cadherin) mutation and gastric cancer: Genetics, molecular mechanisms and guidelines for management. Cancer Management and Research, 11, 10477–10486. https://doi.org/10.2147/CMAR.S208818

Soleyman-Jahi, S., Nedjat, S., Abdirad, A., Hoorshad, N., Heidari, R., & Zendehdel, K. (2014). Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. PloS One, 10(4), e0122316. https://doi.org/10.1371/journal.pone.0122316

Suzuki, H., Itoh, F., Toyota, M., Kikuchi, T., Kakiuchi, H., Hinoda, Y., & Imai, K. (1999). Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. International Journal of Cancer. Journal International Du Cancer, 83(3), 309–313. https://doi.org/10.1002/(sici)1097-0215(19991029)83:3<309::aid-ijc4>3.0.co;2-z

Tamura, G., Yin, J., Wang, S., Fleisher, A. S., Zou, T., Abraham, J. M., Kong, D., Smolinski, K. N., Wilson, K. T., James, S. P., Silverberg, S. G., Nishizuka, S., Terashima, M., Motoyama, T., & Meltzer, S. J. (2000). E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. Journal of the National Cancer Institute, 92(7), 569–573. https://doi.org/10.1093/jnci/92.7.569

Thomassen, I., van Gestel, Y. R., van Ramshorst, B., Luyer, M. D., Bosscha, K., Nienhuijs, S. W., Lemmens, V. E., & de Hingh, I. H. (2014). Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors: Peritoneal Carcinomatosis of Gastric Origin. International Journal of Cancer. Journal International Du Cancer, 134(3), 622–628. https://doi.org/10.1002/ijc.28373

Venza, M., Visalli, M., Catalano, T., Biondo, C., Beninati, C., Teti, D., & Venza, I. (2016). DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma. Oncology Reports, 35(4), 2451–2460. https://doi.org/10.3892/or.2016.4618

Virgilio, E., Giarnieri, E., Giovagnoli, M. R., Montagnini, M., Proietti, A., D’Urso, R., Mercantini, P., Valabrega, S., Balducci, G., & Cavallini, M. (2018). Gastric cancer cells in peritoneal lavage fluid: A systematic review comparing cytological with molecular detection for diagnosis of peritoneal metastases and prediction of peritoneal recurrences. Anticancer Research, 38(3), 1255–1262. https://doi.org/10.21873/anticanres.12347

Vleminckx, K., Vakaet, L., Jr, Mareel, M., Fiers, W., & van Roy, F. (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66(1), 107–119. https://doi.org/10.1016/0092-8674(91)90143-m

Yoo, C. H., Noh, S. H., Shin, D. W., Choi, S. H., & Min, J. S. (2000). Recurrence following curative resection for gastric carcinoma: Recurrence of gastric cancer afer resection. The British Journal of Surgery, 87(2), 236–242. https://doi.org/10.1046/j.1365-2168.2000.01360.x

Yu, Q.-M., Wang, X.-B., Luo, J., Wang, S., Fang, X.-H., Yu, J.-L., & Ling, Z.-Q. (2012). CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer: CDH1 Methylation Predicts Poor Prognosis. Journal of Surgical Oncology, 106(6), 765–771. https://doi.org/10.1002/jso.23116

Zeng, W., Zhu, J., Shan, L., Han, Z., Aerxiding, P., Quhai, A., Zeng, F., Wang, Z., & Li, H. (2015). The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review. Drug Design, Development and Therapy, 9, 2149–2157. https://doi.org/10.2147/DDDT.S75429

Zhu, B.-Y., Yuan, S.-Q., Nie, R.-C., Li, S.-M., Yang, L.-R., Duan, J.-L., Chen, Y.-B., & Zhang, X.-S. (2019). Prognostic factors and recurrence patterns in T4 gastric cancer patients after curative resection. Journal of Cancer, 10(5), 1181–1188. https://doi.org/10.7150/jca.28993

Downloads

Published

25/01/2022

How to Cite

OLIVEIRA, A. C. F. M. de .; MODESTO, A. A. C. .; MOREIRA, F. C. .; ARAÚJO, T. M. T. .; SILVA, M. G. de O. P. da .; ASSUMPÇÃO, P. P. .; ISHAK, G.; BORGES, B. do N. .; KHAYAT, A. S. . CDH1 methylation in peritoneal washes as a prognostic factor for gastric cancer. Research, Society and Development, [S. l.], v. 11, n. 2, p. e27911225758, 2022. DOI: 10.33448/rsd-v11i2.25758. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/25758. Acesso em: 25 apr. 2024.

Issue

Vol. 11 No. 2

Section

Health Sciences

License

Copyright (c) 2022 Ana Carolina Favacho Miranda de Oliveira; Antonio André Conde Modesto; Fabiano Cordeiro Moreira; Taíssa Maíra Thomaz Araújo; Marcelli Geise de Oliveira Prata da Silva; Paulo Pimentel Assumpção; Geraldo Ishak; Bárbara do Nascimento Borges; André Salim Khayat

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.